Changes in neural activity were decreased in animals pre-exposed to 5-HT and <i>mod-1</i> mutants when the worms switched their locomotive direction. by Haruka Mori (8082215)

“…(F) Decreasing levels of RID neural activity during the transition periods from forward to backward locomotion in mock, 5-HT pre-exposed (p = 1.3 × 10⁻³), and <i>mod-1</i> mutant (p = 5.4 × 10⁻⁴) animals. …”

Demographic of the study participants, urinary arsenic species and IL-17A cytokine. by Faruque Parvez (13136)

Subjects:

VAMP2 decreases 5-HT uptake and SERT cell surface expression in HEK-293 MSR cells by reducing the delivery rate of the transporter to the plasma membrane. by Heidi Kaastrup Müller (570207)

Subjects:

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

PBA decreases ER stress induced apoptosis. by Jesse C. Wiley (234079)

“…With the addition of 1 mM PBA, the number of detached cells decreased to non-statistically significant levels in the tunicamycin and thapsigargin treated cells, while the numbers remained statistically different in the BFA treated cells. …”

Decrease in the portion of non-aggregated protein (γ_non-agg) in the course of DTT-induced aggregation of BSA (1 mg/ml) at 45°C. by Vera A. Borzova (456538)

Knocking down of TRIM59 decreased the expression of cell cycle proteins. by Weihua Zhan (830500)

Efficacy of selection decreases at the expansion front and as a function of long-term effective population size. by Quentin Rougemont (3249753)

Prolonged Htr2b activation decreases ATP content and coupled mitochondrial respiration in MIN6. by Luis Rodrigo Cataldo (3701206)

Pharmacological Mechanism of the Non-hallucinogenic 5‑HT_2A Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

“…Ariadne emerges as a prototype of a new drug class, non-hallucinogenic 5-HT_2A agonists, with considerable therapeutic potential across psychiatric and neurological indications.…”

Pharmacological Mechanism of the Non-hallucinogenic 5‑HT_2A Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

“…Ariadne emerges as a prototype of a new drug class, non-hallucinogenic 5-HT_2A agonists, with considerable therapeutic potential across psychiatric and neurological indications.…”

MPI knockdown decreases migration of human glioblastoma cells. by Aurélie Cazet (644004)

GroEL1 decreases EPC number and function. by Yi-Wen Lin (143406)

Ifit2 deficiency results in decreased neuroinflammation upon RSA59 infection. by Jayasri Das Sarma (652473)

Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders by Ajay Singh (227970)

Effect of 5-HTR blockade on error pattern in the work/delay task. by Yukiko Hori (299784)

Subjects:

DataSheet1_A Non-Synonymous Point Mutation in a WD-40 Domain Repeat of EML5 Leads to Decreased Bovine Sperm Quality and Fertility.docx by Eriklis Nogueira (7475576)

Quantitation of the decrease in viability of schistosomula caused by GSK343 treatment at different concentrations and incubation times. by Adriana S. A. Pereira (5900249)

Quercetin decreases proliferation (A) and induces apoptosis (B) in cultured PASMC from control rats. by Daniel Morales-Cano (668199)

Proliferation marker Ki-67 is decreased by rLOX-PP treatment. by Manish V. Bais (333481)